Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Efficacy of Stereotactic Radiotherapy and Whole-Brain Radiotherapy with Immunotherapy in Driver Gene-Negative NSCLC Patients with Brain Metastases: An IPTW Analysis from Real-World Data

  • By

  • Erha Munai

  • Lisi Sun

  • Amu Jike

  • Dan Tao

  • Nan Li

  • Jiang He

  • Yu He

  • Liang Du

  • Wei Zhou

  • Yongzhong Wu

  • Dingyi Yang

  • June 22, 2026

Share

Original Source(s)

Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene–negative NSCLC with brain metastases: a real-world IPTW analysis

  • by Erha Munai, Lisi Sun, Amu Jike, Dan Tao, Nan Li, Jiang He, Yu He, Liang Du, Wei Zhou, Yongzhong Wu, Dingyi Yang

  • June 22, 2026

Related Content

Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report

Toward Precision Cardio-Oncology in Breast Radiotherapy

Correction: Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer